One company that should be on your radar is Chemed Corp. (CHE). The stock of this healthcare company has seen its Zacks Rank surge over the past four weeks, moving from Hold territory to its current position as a Strong Buy.
A key reason for this move has been the positive trend in the earnings estimate revisions picture. For CHE’S full year estimate, we have seen 1 estimate go higher in the past 30 days, compared to no downward revision. This trend has helped the consensus estimate to trend higher, going from $4.84 a share a month ago to its current level at $5.22.
This positive shift in estimates has made some investors take notice and buy the stock. In fact, CHE has seen some pretty solid trading lately, as the company has moved higher by 11.0% in the past month.
If Chemed Corp. can keep up this great momentum on the earnings estimate front and continue to impress analysts, we could see more gains ahead for this company, suggesting that you might want to put CHE on your watch list for the future.
Other top-ranked stocks worth considering in this space include Almost Family Inc. (AFAM), LCA-Vision Inc. (LCAV), with a Zacks Rank #1 (Strong Buy) and China Cord Blood Corporation (CO) with a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment